z-logo
open-access-imgOpen Access
HBsAg Loss Due to Tenofovir Treatment for HBV Reactivation Following DAAs Therapy in One Patient with HBV-HCV Coinfection
Author(s) -
Danni He,
Wei-Zhe Li,
Shibo Huang,
Liping Zhang,
Jingjing Li,
Zhaohai Zeng,
Zujiang Yu,
QingLei Zeng
Publication year - 2021
Publication title -
infectious diseases and immunity
Language(s) - English
Resource type - Journals
eISSN - 2096-9511
pISSN - 2693-8839
DOI - 10.1097/id9.0000000000000009
Subject(s) - medicine , hbsag , ombitasvir , entecavir , coinfection , dasabuvir , hepatitis b virus , virology , paritaprevir , hepatitis b , lamivudine , gastroenterology , virus , hepatitis c virus , ribavirin

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here